Abstract
Introduction

26
The independent verification of research results is the bedrock of experimental research. In 2011-27 2012 scientists at pharmaceutical companies reported that they were unable to replicate 80-90% of 28 the findings in landmark research papers 1, 2 , thus documenting a "reproducibility crisis" in the life 29 sciences. A survey conducted by Nature in 2016 with 1,576 researchers suggested that 52% of 30 participants agree on the existence of a significant "crisis" of reproducibility, and that publications in 31 biology and medicine were deemed less reproducible than those in chemistry and physics 3 . In the 32 last five years the scientific community has started to address the problem by promoting 33 transparency in scientific publications 4 , analyzing and identifying key factors that influence 34 reproducibility [5] [6] [7] [8] , and by independently replicating selected results from high-profile papers, e.g. in 35
the field of cancer biology [9] [10] [11] . These efforts have already resulted in better documentation of 36 protocols and reagents in the scientific literature and, through mandating the deposition of primary 37 data in public repositories, in an improved ability to independently verify conclusions derived from 38 published data. Whereas these initial steps are useful, they are clearly not sufficient. Multiple factors 39 can contribute to poor reproducibility, including poor study design, improperly applied statistical 40 methods, lack of data sharing and transparency, the incompetence of researcher, inappropriate or 41 poorly reproducible measurement methods, incomplete description of experimental details and 42 incorrect or mislabeled reagents 7, 8 . Apart from these technical issues, the complexity inherent in 43 biological systems further challenges the reproducibility of life science research. At present it is 44 generally unknown how genomic and environmental perturbations affect the molecular makeup and 45 ensuing phenotypic response of a cell or organism, and how (genetically) different cells or organisms 46 react to identical perturbations. 47 
48
Human cancer cell lines are widely used in biological and biomedical research. They represent a 49 source of biological material that can be perpetually regenerated, is technically straightforward and 50 4 economical to maintain and is assumed to deliver reproducible results. For these reasons human 51 cancer cell lines are frequently preferred over primary cultures or in vivo research. Several recent 52 studies have highlighted significant problems with the use of human cancer cell lines, including cell 53 line misidentification, cross-contamination and poor annotation, which altogether impair the 54 reproducibility of results obtained from such cell lines between labs [12] [13] [14] [15] . Consequently, the correct 55 nomenclature of cultured cells has received significant attention. For instance, short tandem repeat 56 profiling has been proposed to correctly identify cells used 15, 16 . However significant, experimental 57 artifacts like contamination or mislabeling are only a part of the problem and could, in principle, be 58 alleviated by careful experimentation. To date it has not been thoroughly explored to what extent 59 cultured cell lines remain genetically stable over time and to what extent potential genotypic 60 variability induces proteotype and phenotype variations in a given cell line with the "same name" 61 across laboratories. This question deserves critical consideration because anecdotal, non-systematic 62 observations suggest that many cultured cell lines might be genomically unstable 17, 18 . Therefore, 63 even careful experimentation cannot fully alleviate the problem. 64 
65
In this study we have quantified the degree of genomic variability, its effects on multiple levels of 66 gene expression and a phenotypic response using HeLa cells as a model. HeLa cells originated from 67 a cervical cancer tumor in a patient-Henrietta Lacks-in 1951 19 and have been extensively used 68 since. Several reasons led us to choose HeLa cells for this study. First, HeLa is the first successfully 69 immortalized human cell line which has widely impacted biological studies. These include several 70 studies for which Nobel Prizes were awarded, such as the development of the polio vaccine 20 , the 71 discovery of telomeric activity 21 , and the linkage between human papilloma virus and cervical 72 cancer 22 . More than 97,000 publications-nearly 0.3% of all publications curated in PubMed-have 73 directly used or directly referenced HeLa cells. Second, HeLa cells have been reported for decades to 74 contaminate and dominate other cell lines 23, 24 and conversely, they are less likely to be 75 contaminated themselves, minimizing the possibility of cell misidentification for HeLa-focused 76 studies 15, 16 . Third, due to extensive genome instability during passaging and between labs HeLa 77 cells were reported to contain an exceptional number of genomic variants 18, [25] [26] [27] [28] . For example, the 78 currently widely used HeLa variants include HeLa CCL2, the "original" HeLa cell line; HeLa S3 79 (also called CCL2.2), the third clone isolated from an early HeLa culture; and HeLa Kyoto, the 80 popular Kyoto version. Whole genome sequencing of HeLa Kyoto 29 and HeLa CCL2 30 strains were 81 carried out separately, and significant variation of sequence, gene copy numbers, and chromosomes 82
were reported between the two 30 . Furthermore, different HeLa Kyoto clones between labs were 83 reported to vary in terms of mRNA expression 18 . However, little is known about the manner by 84 which such genomic variability affects the proteomes or phenotypes of the different HeLa strains 85 between individual labs, the effect of successive passages within a stock-derived line on its 86 molecular make up, and how these would affect a biological research outcome 31, 32 . 87
88
Proteins catalyze and control most biological processes. The concentration and the synthesis and 89 degradation rates of proteins in many scenarios cannot be predicted from corresponding mRNA 90 abundance [33] [34] [35] . Over the last decade the proteome has become precisely measurable and it has been 91 recognized that the acute state of the proteome-the proteotype-is a useful indicator of the cellular 92 state and thus important for the understanding of disease phenotype, development, pharmacological 93 responses, and many other aspects of life science research 36, 37 . The last five years have also 94 witnessed significant technological improvements in mass spectrometry (MS)-based proteomics 95 regarding proteome coverage and measurement reproducibility of large sample cohorts. In particular, 96 data-independent acquisition (DIA) methods, exemplified by SWATH mass spectrometry (SWATH-97 MS) combined with targeted data extraction has achieved unprecedented reproducibility, generating 98 quantitative matrices for thousands of proteins measured across multiple samples [37] [38] [39] . Recently, the 99 statistical strategies controlling the quality of protein identification and quantification in large-scale 100 6 SWATH-MS have matured 40, 41 , and SWATH-MS has proven to be reproducible in a cross-lab study 101 for ~5,000 proteins quantified in mammalian cells 42 
Results
110
HeLa cell variants from different laboratories have different and rapidly 111 evolving genotypes.
112
To survey the genomic, proteomic and transcriptomic similarity of HeLa cells across research 113 groups, we reached out to 13 laboratories to provide samples of HeLa cells used in their group 114 (Figure 1) . The cell lines were numbered randomly from HeLa 1 to HeLa 13. Four laboratories 115 shared the 7 th Passage (P7) of an initial HeLa CCL2 cell line culture (the original version of HeLa, 116 directly purchased from ATCC). These P7 cells were then separately cultured in three labs until 117 Passage 15 or 20 (P15 or P20), a stage where cells are generally regarded as still acceptable for 118 biology research (HeLa 6, 7, and 13) (Figure 1a) . The fourth group receiving the common P7 cells 119 provided both P7 (HeLa 14) and P50 cells (HeLa 12) which allowed us to identify molecular 120 alterations occurring within the timeframe of ca. 3 months. In total the 14 HeLa cell variants 121 comprised seven HeLa CCL2 lines, one HeLa S3 line, six HeLa Kyoto lines including one line of 122 unknown provenance -HeLa 3 -which was later identified as HeLa Kyoto using data from this study. 123
To eliminate potential differences caused by varying culturing conditions and techniques between 124 laboratories and to generate the number of cells (>10 7 cells per line) required for the multi layer 125 molecular analyses, we centrally cultured all 14 cell lines for an additional three passages in our 126 group. To minimize experimental variability, the same researcher cultured the cells using the same 127 culture media and protocol. 128
129
As a starting point for the evaluation of HeLa cell heterogeneity, we measured gene copy number 130 variation (CNV) by array-CGH (aCGH). Previous studies reported genome instability within and 131 between different HeLa strains 18, [25] [26] [27] [28] . To investigate and display the ploidy variation of the strains 132 studied we projected the CNV data onto the reference human genomic map (Figure 1b) . We 133 discovered pervasive CNV differences organized by domains, large chromosomal segments, and 134 even whole chromosomes. Particularly notable were ploidy changes at Chromosomes (Chr) 1, 2, 6, 135 9, 10, 17, 19, 21, 22, and X. (Figure 1b) . On average, the HeLa genome of all cells tested had an 136 overall hypertriploid state, as reported 29, 30 . However, distinctive patterns differentiated the Kyoto 137 and CCL2 lines: HeLa CCL2 lines had 1.87-times as many genes with two copies and 0.7-times as 138 many genes with three copies compared to the Kyoto lines, suggesting that the original HeLa CCL2 139 cells have a generally smaller genome than Kyoto variants (Supplementary Figure 1) . Even within 140 the CCL2 and Kyoto groups, significant CNVs could be observed between samples provided from 141 different laboratories, albeit at a smaller scale, exemplified by the distal locus on Chr8 (Figure 1b) . 142
Moreover, HeLa 11 showed a deviating pattern in multiple chromosomes compared to other HeLa 143 CCL2 cells. The distribution of coefficient of variation of all the genes encoded by different 144 chromosomes among all cell lines revealed genome-wide DNA dosage differences, e.g., Chr13, 14, 145 and 18 seemed to be relatively stable among HeLa cell variants tested (Figure 1c) . 146
147
To investigate the rate of genome variability progression, we investigated the CNV divergence 148 between HeLa 14, the original ATCC HeLa CCL2 cell line at P7, and HeLa 12, the direct descendent 149 of HeLa 14 at P50. The observed fold-changes were visualized at each chromosome (Figure 1b 160 We then posited that these CNVs would impact gene expression patterns of the respective HeLa 161 strains at steady state. Therefore, we further performed transcriptomic profiling by mRNA 162 sequencing, steady state proteomic profiling by SWATH-MS, and protein turnover rate 163 determination by pulse-chase SILAC (pSILAC) labeling followed by SWATH-MS. pSILAC 164 measures the incorporation rate of isotopically heavy amino acids into newly synthesized proteins 43- 165 45 . Experts in the respective techniques, blinded to the cell identities, carried out the measurements at 166 each layer of gene expression, thus contributing to a unique multi-layer dataset of related cultured 167 cells (Figure 2) . 168 169 Collectively, we quantified transcripts for 11,365 genes (after filtering by average RPKM>1 among 170 all 14 lines, Figure 2a) . Using the state-of-the-art SWATH-MS measurements 41 41 , for details see Method & Supplementary Figure 2) . By absolute label free 173 quantification, the abundance of the 5,030 proteins was determined to center at 10,000 copies per 174 cell, spanning a range of abundance from 100 to >10 6 copies per cell (Figure 2b) . Using pSILAC 175 9 SWATH-MS, we quantified the proxy turnover rate (i.e., Kloss, see Method) of a consistent set of 176 2,084 proteins in each HeLa cell line. Together, these analyses yielded 4,656 genes with both mRNA 177 and protein measurements, and 2,011 genes with all three layers of data, presenting a substantial 178 resources for gene expression studies in cells (Figure 2a & Supplementary Figure 3) . 179
180
To assess the quantitative reproducibility of SWATH-MS, we performed correlation analysis 181 We next explored the observed difference between HeLa CCL2 and Kyoto groups in more detail. 210
We firstly aligned the CCL2/Kyoto ratios at CNV, mRNA, protein, and Kloss levels with the 211 respective loci in the human genome (Figure 2l) . We found that the transcriptome and proteome 212 differences largely followed the gene copy number imbalance reflected by CNV ratios, whereas the 213 Kloss ratios showed a higher degree of variation. We then examined how differences between CCL2 214
and Kyoto compare to the differences between other human cell lines of different types and origins. 215
We referred to a previous published data set which contains the RNA-seq data for 1,001 molecularly 216 annotated human cancer cell lines (GDSC panel) 50, 51 , and used t-SNE analysis to plot the variance 217 at the transcriptomic level between HeLa cells and the GDSC cell lines (Figure 2m) . We found that 218 based on transcriptomic data, HeLa CCL2 and Kyoto groups are as distinct from each other as are 219 cancer cell lines from different tissue types. Furthermore, the published HeLa cell in the GDSC panel 220
(the strain identity not mentioned) clustered with our CCL2 cells, indicating that it is likely a HeLa 221 CCL2 cell line. To corroborate this analysis, we performed t-SNE for proteome and Kloss data by 222 comparing HeLa cells to the primary skin fibroblast cells isolated from 11 Down Syndrome and 11 223 control individuals and a monozygotic twin pair discordant for trisomy 21 for which the same 224 proteomic techniques (i.e., SWATH-MS and pSILAC-SWATH) were employed 45 (Supplementary 225 Figure 5 ). We found that all HeLa cell variants were clearly separated from fibroblast cells by both 226 protein abundance and turnover rates. Interestingly, the quantitative proteomic variance between 227
HeLa cells which is associated with substantial karyotypic differences (Figure 1) transcripts showed increased expression levels, whereas 316 transcripts showed decreased expression 248 levels in P50 cells. These 731 transcripts were significantly enriched in several distinct biological 249 processes annotated in GO (Figure 3b) We next asked whether these differential transcripts profiles were translated into differential protein 257
profiles. Using SWATH-MS, we were able to quantify proteins corresponding to 166 transcripts out 258 shown as representative examples. It is apparent that the numerous CNVs led to significant mRNA 272 changes that did not translate into the corresponding protein levels. Also, there was a decrease in 273 total variance summarized at each layer from mRNA to protein and to protein turnover rate 274 (Supplementary Figure 7) . These results suggest the existence of global buffering mechanisms 275 along the axis of gene expression from transcripts to proteins 34 . 276
277
To dissect post-transcriptional protein expression control, we and others have emphasized the 278 importance of analyzing across-gene, within-gene, and gene specific correlations between omics data 279 sets 34, 35 . Thus we performed correlation analyses between CNV, mRNA, protein, and Kloss values 280 comparing both, across-gene and within-gene patterns. As an example, the absolute-scale data from 281 an arbitrary reference cell e.g. HeLa 1 (a HeLa Kyoto cell) were correlated between omics layers in 282 the across-gene manner. (Figure 4d ). HeLa 1 was further compared relatively to other lines e.g. 283 HeLa 14, a HeLa CCL2 line by correlating the fold-changes at each layer (Figure 4e ). The 284 mRNA~protein correlation was quantitatively strong for both absolute and relative scales (Spearman 285 correlation coefficient rho=0.51 and 0.49), reinforcing the previous notion that protein levels at 286 steady state are primarily determined by mRNA levels 34, 57 . Furthermore, the protein turnover rate, 287
Kloss, was found to fine-tune gene expression in general, showing small but non-negligible positive 288 correlations to CNV and mRNA levels. The absolute protein~Kloss correlation rho was -0.18 289 (Figure 4d ), denoting the fact that highly abundant proteins are less strongly regulated by protein 290 degradation rates than proteins expressed at lower levels 58 . Notably, CNV heavily determines the 291 mRNA levels when we consider the relative difference between two cell lines (rho=0.45), but is only 292 marginally significant for predicting mRNA copies within one cell line (rho =0.12). Similar trends 293 were found for protein levels (rho =0.19 vs. 0.04). This illustrates the importance of considering both, 294 across-gene and within-gene analyses. 295
296
To further evaluate gene-specific predictions we plotted the distribution of genome-wide Spearman's 297 rho calculated across the 14 HeLa cells. Consistently, we found the highest correlations between14 conserved information flow along the central dogma axis for most genes. The observed 300
CNV~protein correlation was less strong (averaged rho=0.17) in part due to the interspersed mRNA 301 level control. Furthermore, the CNV~Kloss and mRNA~Kloss correlations were 0.16 and 0.11, 302 respectively, again supporting the notion that for many genes protein turnover functions as a 303 buffering step, shaping the quantitative proteome of the HeLa cells tested (Figure 4e-f) . 304
305
The maintenance of protein complex stoichiometry was reported as an efficient buffering mechanism 306 against aneuploidy stress in different systems 34, 53, 54, 59 . We previously generated direct protein 307 degradation measurements by pSILAC-SWATH to illustrate this proteostasis mechanism in human 308 trisomy 21 45 . Here we tested the significance of protein complex stoichiometry control among 14 309
HeLa strains, by comparing the cross-layer correlations between those proteins annotated in any 310 stable complex in the CORUM database ("complex_in" group) and those that are not annotated as 311 complexes in CORUM ("complex_out" group) (Figure 4g) . We found that the CNV~mRNA 312 correlations are not significantly different between "complex_in" and "complex_out" groups 313 (P=0.064, Mann-Whitney test). In stark contrast, the "complex_in" proteins tend to have 314 significantly weaker mRNA~protein correlations (P=7.3 -9 ) and much stronger mRNA~Kloss 315 correlations (P=7.5 -5 ) than "complex_out" proteins, demonstrating the post-translational constraint of 316 protein complex stoichiometry control for "complex_in" proteins, a process that affected 317 mRNA~protein correlation. All the distributions of CNV~Kloss, CNV~protein, and protein~Kloss 318 correlations can be explained, in part by protein degradation mediated buffering of complex 319 components (Figure 4g) . We anticipate that the statistical significance of above buffering 320 mechanisms will further increase if the protein complex components were derived directly from cell 321 specific experiments e.g., by SEC fractionation 60 . 322
323
We next analyzed the layered gene expression variability of specific gene sets in the tested HeLa 324 cells. HCA indicates that the variations at mRNA, protein and protein turnover levels do not affect 325 genes equally (Figure 4h) . The majority (~75%) of genes showed consistent variation extent 326 between mRNA and protein levels, whereas Kloss particularly strongly affected a subset of genes. 327
To determine whether such regulatory patterns are functionally relevant, we used a recently 328 among the highest observed. Thus, the protein turnover of the mitochondrial proteome is likely to be 342 important in buffering aneuploidy stress and the resultant mRNA changes in and between HeLa cells, 343 which agrees with our previous report on human trisomy 21 45 . Conversely, there was a very weak 344 correlation of mRNA~Kloss for plasma membrane proteins, suggesting a weaker role of protein 345 turnover in shaping variable membrane proteome between HeLa cells. Therefore, the extent of 346 variation at the transcriptional, protein, and post-translational level seems to be frequently protein 347 specific and determined by the protein functions and their cellular locations. 348
In summary, these results indicate that the translation of genotypic variability observed between 349
HeLa cell variants into proteotypic variability is controlled by a multitude of global processes, 350 including the control of protein complex stoichiometry and organelle specific protein turnover rates. 351
352
HeLa proteotypic variability tightly links to phenotypic variability 353 We then analyzed phenotypes to better understand the consequences of the molecular heterogeneity 354 of the tested HeLa cells. We firstly used molecular imaging methods, specifically DAPI staining to 355 highlight the nucleus and RFP labeling for F-actin visualization. We also counted cell numbers to 356 that the absolute protein copies of Cyclin-dependent kinases 1, 2, 7 (CDK1, CDK2, and CDK7) were 366 on average 57.7%, 46.8% and 81.2% higher in the Kyoto group than in the CCL2 group of cells 367 (Supplementary Figure 10) , possibly accelerating the cell doubling observed 62 , thus establishing a 368 proteotype-phenotype link. 369
370
Besides readily apparent phenotypes such as cell morphology and doubling time, we sought to 371 inspect the consistency of the HeLa cells tested in their ability to respond to the same stimulus or 372 perturbation. MicroRNAs (miRNAs) are known to suppress target gene expression in a sequence 373 specific manner 63 . We therefore asked whether different HeLa cells could render different proteomic 374 responses to perturbation via miRNA transfection. We selected mimics of Let7, which is a well-375 known, highly conserved miRNA that has been shown to play a central role in development and 376 tumor suppression [64] [65] [66] . Using identical protocols, the set of 14 HeLa cell lines were transfected with 377 Figure 12) . Further microbiological experiments 398 suggested that the first docking step which precedes ruffling, entry and intracellular growth of 399 S.Tm 68, 69 was impaired in Let7 treated HeLa CCL2 cells (Supplementary Figure 12) . We therefore 400 repeated the S.Tm infection experiment for all the HeLa cells transfected with Let7d (Figure 5d-e (Figure 5d) . To further explore 406 this effect, we compared wild-type Salmonella and a non-invasive mutant (S.Tm ΔT1) for their 407 ability to infect HeLa 11, HeLa 3, and HeLa 14 over a range of multiplicities of infection (moi) from 408 4 to 250. We found that HeLa 11 indeed showed lower overall infection rates at the respective moi's 409 compared to the other cells (Figure 5f ). We therefore revisited the steady state proteome of HeLa 11. 410
Reassuringly, we found that compared to other HeLa CCL2 cells, HeLa 11 has the lowest expression 411 of the Arp2/3 complex which has a well-established role in bacterial internalization into host cells by 412 initiating membrane ruffles [68] [69] [70] . Remarkably, all the seven subunits of the Arp2/3 complex that were 413 quantified in the proteomic dataset followed the same pattern (Figure 5g) , which could explain the 414 reduced S.Tm infection in HeLa 11. We used the STRING database to perform gene set enrichment 415 for the 178 proteins that were differentially expressed between HeLa 11 and other CCL2 cells (linear 416 modeled test, adjusted P <0.05), and again we found the membrane-bounded vesicle (GO:0031988) 417 71 was most significantly enriched (adjusted P=3.61E-12, Figure 5h) . We finally performed a 418 docking experiment 69 by counting the S.Tm bacteria that remained bound to the respective HeLa 419 cells after extensive washing. We confirmed a less pronounced S.Tm docking phenotype in HeLa 11 420 compared to HeLa 14, which may further indicate that HeLa 11 has a different membrane topology 421 or composition (Figure 5i) . Such membrane topology effects are known to affect the rate of S.Tm 422 docking to host cells 72 . These results indicate that the different molecular response to Let7 of the 423 tested HeLa cells directly affected a bacterial infection phenotype. 424
425
To summarize, our data show that the set of proteins that constitute the cell line specific expression 426 response provide useful information about the molecular basis underlying the observed phenotypic 427 differences such as doubling time and miRNA modulated bacterial infection. Moreover, all the raw abundance tables at each layer for any gene or genes queried can be easily 439 downloaded using gene symbol or SwissProt ID (Supplementary Figure 13) . We believe that this 440 website, together with the knowledge which can be derived from it (Supplementary Figure 14) will 441 provide beneficial for future research into specific genes and their behavior in complex systems. interpreted as the results of incompetence or fraud. In an attempt to bring the discussion to a 451 rationale, evidence-based level the overall problem has been broken down into several specific issues 452 [5] [6] [7] [8] . Some of these have been already addressed by the community and have led to changes in 453 research and publication practice. These include the more detailed documentation and validation of 454 research reagents, data collection methods, data openness and transparency, and statistical analyses 7,
455
. 456 457
In this paper we study an additional, as yet poorly documented issue affecting reproducibility of 458 research results, the effects of genomic variability in commonly used cells lines on gene expression 459 patterns and phenotypes. Genomic variability is an inherent essential property of evolving biological 460 systems. Therefore, whereas the results of this study were generated from cultured cancer cell lines, 461 they are likely also of significance to the study of populations of single or multicellular organisms, 462 particularly in the context of the emerging personalized/precision paradigm in medicine 74 . The 463 importance of reporting research results in the context of a well defined genotype has recently been 464 highlighted by ageing research in C. elegans 75 . Initially a study published in 2010 76 found as main 465 conclusion that treatment of adult hermaphrodite worms with SOD/catalase mimetics caused a large 466 increase in lifespan. This result could not be reproduced by peers 77 an situation that was recently 467 explained by the discovery that genetic variation of C.elegans strains between labs at least partially 468 explained the previously anecdotal observations of variation in lifespan outcomes 75, 78 . 469
470
Like C.elegans, human cancer cell lines are another broadly used material in biological and 471 biomedical studies. In most of these studies, cell lines are assumed to be genetically stable rather 472 than heterogeneous at the population level 34 . Our data suggest molecular variability of a cell line as 473 a significant source of apparent irreproducibility even if all other parameters of an experiment are 474 correctly reported and equivalently performed between different labs. The data also show that in 475 HeLa cells, and by inference in other cells with instable genomes, the molecular variability is rapidly 476 evolving, challenging the ability to generate reproducible research results over time even in the same 477 lab. The validation of research reagents and materials is also crucial as it lays the experimental 478 foundation. Previously, discussions around the variability of cells as a source of irreproducible 479 results have centered around experimental error like mislabeling misidentification of cells [12] [13] [14] [15] . In 480 this report we focus on the fundamental issue of biological variability which we believe to be more 481 prevalent and significant than simple experimental errors. 482
483
Previously genome sequencing studies were reported on HeLa Kyoto 29 and HeLa CCL2 30 strains. 484
In this study, we performed a proteome centric, multi-omics investigation of HeLa cells across 13 485 labs worldwide to evaluate their heterogeneity by focusing on CNV related dosage changes along the 486 axis of gene expression. We find that the HeLa cells tested show significant genomic variability and 487 rapid evolution of genomic variability, likely due to genomic instability. We further show complex, 488 non-linear translation of genotypic variability into expressed transcript and protein patterns. Finally, 489
we document the phenotypic consequences of the proteomic variability among these HeLa cells. sensitivity to monofunctional alkylating agents, and the speculated reason was mutation induction in 495 a line of HeLa cells 80 . However, there are no investigations to assess the molecular nature of such 496 differences at a systems-wide scale. Indeed, although HeLa cells are widely used and yield ~0.3% of 497 the total publications listed in PubMed, only a tiny fraction of these papers (< 2% based on keyword 498 search in PubMed) clearly indicated whether they used HeLa Kyoto or HeLa S3. For most of the 499 97,000 publications, researchers simply report "HeLa" in their method section. 500
501
Our study extends the molecular analyses to the assessment of genotypic, proteotypic and phenotypic 502 diversity and has specific implications for how the HeLa cell identities should be documented in 503 future scientific publications. Firstly, we found that HeLa CCL2 and Kyoto cells are consistently 504 different at all layers of biology. There are significant differences in cell morphology, doubling time, 505 karyotypes, steady state mRNA, protein expressions, and protein turnover rates. Furthermore, the 506 difference between HeLa CCL2 and Kyoto also results in distinct proteomic responses to Let7 507 transfection which can tune protein synthesis from thousands of genes 81 . The gene expression 508 variance between CCL2 and Kyoto is as large as that between many other cell lines of different 509 tissue origins (Figure 2m) . Therefore, we strongly suggest that all future HeLa related studies should 510 at least clearly report the identities of CCL2 or Kyoto for the cells used. Secondly, HeLa S3, the third 511 lineage of HeLa CCL2, did not show distinguishable pattern from CCL2 lines in most of our 512 measurements, which might suggest that HeLa S3, when used, could achieve higher reproducibility 513 to HeLa CCL2 than Kyoto cells. Thirdly, we discovered substantial, biologically meaningful 514 divergence of HeLa CCL2 cells after 3 months of culturing that involved copy deletions or gains of 515 some whole chromosomes, 6-7% of gene differential expressions, and quantitative changes of 516 pathways. This suggests that even during studies of moderate duration the molecular makeup of the 517 cells will change. Hence, we recommend the use of early passages of HeLa CCL2 cells directly 518 from the providers like ATCC or minimally of cells with well-documented history of culturing. 519
Finally, phenotypes such as growth rate and significant resistance to S.Tm infection could be linked 520 to proteotypes (Figure 5) . Thus, it seems conceivable to establish a genome-wide benchmark to a 521 standard HeLa cell line before performing critical experiments. We herein suggest fast proteome 522 profiling and the quantitative comparison to our results along with the present publication would be a 523 cost effective means to document the biochemical state of the specific cells reported in a publication. 524
525
We further suggest that the findings described here derived from HeLa lines are likely generally 526 applicable to other cell lines with instable genomes. For example, the human breast cancer cell line 527 MCF-7, initially derived in 1973 from a malignant pleural effusion, is also a heterogeneous line. As 528 early as 1987 the striking difference of chromosome analysis and the cloning efficiency of four 529 MCF-7 cells from different labs was documented 82 . Compelling ploidy and signaling pathway 530 evidence have been shown for the existence of the triple-negative variants in the MCF cell 531 population 83 . The MCF-7 cells selected for tamoxifen resistance were reported to acquire new 532 phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin 533 sensitivity 84 . Another cell example is HEK293, for which the dynamics of aneuploidy genome in 534 response to cell biology manipulations was discovered by whole-genome sequencing 85 . It is thus 535 imperative to revisit the cell identity and heterogeneity for common cell lines with significant 536 genome instability 79 . 537
538
Compared to the genotype, the proteotype provides a close, real-time, and functional snapshot for the 539 better understanding of phenotypes in cancer cells or clinical tissues 37 . Protein level evidences are 540 widely used by antibody-based technologies such as Western blotting in the enormous literatures, 541 and therefore easily communicative. At present, compared to genomics and transcriptomics 542
profiling, large-scale protein level measurements (i.e., proteomics) have been less frequently 543 reported, also due to technical complexities and challenges. SWATH-MS is a new data independent 544 acquisition technique which combines the comprehensiveness of traditional shotgun proteomics, and 545 the reproducibility and quantification accuracy of the targeted proteomics based on SRM or PRM 38, 546 86, 87 . Besides the high proteome coverage of ~5000 proteins quantified, SWATH-MS shows 547 reproducibility performance that is as high as that of transcriptomics to clearly distinguish whole 548 process replicates from different HeLa strains between labs (Figure 2c) . The harnessing of SWATH-549 MS, pyProphet FDR control 41 , pSILAC, and other strategies essentially broke the technology hurdle 550 to propel the successful evaluation of steady state proteome expression, protein turnover, and 551 responsive proteome diversities between 14 HeLa cells across labs. 552 553 Finally, the multi-omics data for HeLa cells generated in this study provide a high quality resource 554 for understanding gene expression and interplay between layers exemplified by the HeLa Proteome. 
633
Frozen HeLa cells were prepared in each laboratory and sent to the coordinating lab at ETH Zurich 634 in dry ice for centralized culturing. A uniform protocol was used at each site to prepare the cells for 635 shipment. Cells collected from a 15 cm dish were transferred into 1 mL freezing media (70% volume 636 of DMEM; 20% FBS; 10% DMSO). Cells were then placed in -20 °C for 2-3 hours, transferred to -637 80 °C for 24 hours, and stored in liquid nitrogen until delivery. The frozen state of the delivered cells 638 and existence of dry ice were confirmed upon arrival. Additionally, two aliquots of cell pellets were 639 prepared at each site. The HeLa strains were then centrally cultured in the coordinating laboratory 640 using DMEM medium using standard culturing method according to ATCC. 641 642
Determination of Cell Doubling Time 643
The cell doubling time for each HeLa strain was determined using a cell counting CCK-8 Kit 644
(Dojindo Laboratories, Japan). Cells were seeded in triplicate at a density of 2800 cells per well of a 645 96-well plate, and samples were prepared for counting at 5 different time points, 2h, 11h, 24h, 48h, 646 and 72h, respectively. The final doubling time was then calculated (using http://www.doubling-647 time.com/compute.php). The entire experiments were repeated on two cell lines. Cell doubling time 648 differences between whole-process replicates were all less than 2 hours. 649 650
Phenotypic characterization of HeLa cells 651
The plates of HeLa cells where imaged with Molecular Devices ImageXpress microscopes, using 652
MetaXpress software. Imaging settings where adjusted for the highest exposure that did not incur 653 over-exposure, with 14 bit dynamic range and laser-based focusing. We imaged 9 sites per well in a 654 3x3 grid with no spacing and no overlap. Three channels where imaged, with filters for DAPI for 655 imaging the nucleus, GFP for bacteria, and RFP for F-actin. Robotic plate handling was used to load 656 and unload plates (Thermo Scientific). 657 658
Array-CGH (aCGH) analysis 659
Array-CGH analyses were performed using the Agilent Human Genome CGH Microarray Kit G3 660 180K (Agilent Technologies, Palo Alto, USA) with 13 Kb overall median probe spacing (Control is 661 DNA pool of 7 normal diploid individuals). Labeling and hybridization were performed following 662 the protocols provided by the manufacturer. 663 664 aCGH processing and gene copy number detection 665 aCGH measurements of 173,540 genomic probes were used to compute an aCGH log 2 -ratio profile 666 that compares the DNA copy number of each probe in a specific HeLa cell line to normal diploid 667 DNA. aCGH profiles were sorted according to the chromosomal locations of probes and further 668 segmented into chromosomal regions of constant copy number using DNAcopy 88 (R package 669
DNAcopy with settings smooth.region = 3, outlier.SD.scale = 0.5, smooth.SD.scale = 0.25). Copy 670 number values of individual genes (30,237 known canonical genes of hg19/GRCh37) were 671 determined by mapping chromosomal location of genes to obtained aCGH segments. If a gene was 672 covered by a whole segment, then its copy number value was set to the segment-specific log 2 -ratio.
673
If a gene was covered by more than one adjacent segments (break points within a gene), then its copy 674 number value was set to a weighted average of log 2 -ratio of involved segments according to their 675 overlap with the gene. Most parts of the HeLa genomes are known to be triploid 29, 30 . This was also 676 reflected in our aCGH profiles, but the position of the closest peak to the triploid state varied among 677 the different HeLa cell lines. Therefore, we further aligned the obtained gene copy number 678 measurements to ensure that this peak was located at the triploid state for each cell line. 679 680 RNA extraction, library preparation and mRNA sequencing 681
Total RNA was collected using the TRIzol® reagent (Life Technologies) following the 682 manufacturer's instructions. RNA quality was verified on the Agilent 2100 Bioanalyzer (Agilent) 683 and quantity was measured on a Qubit® instrument (Life Technologies).
684
Libraries were prepared with 4 µg of total RNA using TruSeq RNA kit (Illumina) according to 685 manufacturer's instructions. Libraries were sequenced on an Illumina HiSeq2000 machine as 100 bp 686 reads single-end. The reads were aligned to the hg19 human genome using TopHat 89 with standard 687 configurations (no more than 2 mismatches allowed). individual SWATH maps with statistical control (see below) and then aligned between SWATH 822 maps using a novel TRIC (TRansfer of Identification Confidence) 48 . For large-scale targeted 823 proteomics, protein FDR control needs specific attention and should be equally important compared 824 to shotgun proteomics 41, 46 . Therefore, to pursue a strict statistical quality control of peptide and 825 protein-level identification, we used the newly developed PyProphet extended version 41 in the 826 present study. This new version of PyProphet combines the set of scores from OpenSWATH for 827 each peptide query to a single discriminant score by applying semi-supervised learning to best 828 separate decoys from high-scoring targets. Particularly for all the label-free samples, PyProphet was 829 run for conducting q-value estimation 41 for all runs (run-specific context) and in a global fashion 830 (global context). A strategy of two steps of filtering was used: 1) For proteins accepted by PyProphet 831 at FDR <1% in the global context, the sets of peak groups detected at 1% FDR in the run-specific 832 context were included for quantification -this criteria yielded 4335 proteins; 2) For proteins 833 accepted with an FDR <5% in the global context, only those peak groups detected at 1% FDR and 834 also identified in >25% of the total MS runs were accepted. Hours   BUB3  CDK4  ANAPC4  SKP2  CDC16  MAD2L1  ANAPC5  CDKN2C  BUB1B  SFN  CDC27  YWHAH  ESPL1  GSK3B  CCNH  STAG1  ATR  ANAPC7  CDK7  CDK2  CDK1  SMC3  CUL1  TTK  YWHAG  CHEK1  RBX1  HDAC2  PCNA  RAD21  HDAC1  STAG2  CCNB1  CDC23  ORC5  CDC20  CDK6  CDKN2A  ORC4  PLK1  CDC25B  CHEK2  ANAPC1  PRKDC  ORC3  MCM2  MCM4  MCM5  MCM6  MCM7  MCM3  SKP1  CDC45  MAD1L1  SMC1A  YWHAB  YWHAE  CDKN2A  SMAD2  SMAD4  TGFB1  YWHAQ 
